University of Bristol

Overall COVID-19 intensive care mortality has fallen by a third since the start of the pandemic, studies suggest

15-Jul-2020 11:55 AM EDT, by University of Bristol

Newswise — A systematic review and meta-analysis of published studies from three continents shows overall mortality of COVID-19 patients in intensive care units (ICUs) has fallen from almost 60% at the end of March to 42% at the end of May — a relative decrease of one third.

The review, led by the University of Bristol and Royal United Hospitals Bath NHS Trust and published today in Anaesthesia, a journal of the Association of Anaesthetists, also shows ICU mortality for the disease is similar across the three continents included: Europe, Asia and North America.

“The important message is that as the pandemic has progressed and various factors combine, survival of patients admitted to ICU has significantly improved. There were no significant effects of geographical location, but reported ICU mortality fell over time. Optimistically, as the pandemic progresses, we may be coping better with COVID-19,” said lead author Professor Tim Cook, Honorary Professor in Anaesthesia at the University of Bristol and Consultant in Anaesthesia and Intensive Care Medicine at Royal United Hospitals Bath NHS Foundation Trust.

The researchers searched the MEDLINE, EMBASE, PubMed and Cochrane databases up to 31 May 2020 for studies reporting ICU mortality for adult patients admitted with COVID-19. The primary outcome measure was death in ICU as a proportion of completed ICU admissions, either through discharge from the ICU or death. The definition therefore did not include patients still alive on ICU.

A total of 24 observational studies including 10,150 patients were identified from centres across Asia, Europe, and North America. In patients with completed ICU admissions with COVID-19 infection, combined ICU mortality across all the studies up to the end of May was 41.6%. This represents a fall of around a third from the 59.5% ICU mortality seen in the studies up to the end of March.

Professor Cook said: “The in-ICU mortality from COVID-19, at around 40 per cent, remains almost twice that seen in ICU admissions with other viral pneumonias, at 22%.”

There are several possible explanations for the findings regarding decreasing ICU mortality over time.

Professor Cook said: “It may reflect the rapid learning that has taken place on a global scale due to the prompt publication of clinical reports early in the pandemic. It may also be that ICU admission criteria have changed over time, for example, with greater pressure on ICUs early in the pandemic surge.”

The findings are also likely to reflect the fact that long ICU stays, for example, due slow weaning from a ventilator, take time to be reflected in the data. Critical illness associated with COVID-19 can last for long periods, with approximately 20% of UK ICU admissions lasting more than 28 days, and 9% more than 42 days.

The ICU mortality did not differ significantly across continents despite some evidence of variations in admission criteria, treatments delivered and the thresholds for their application. This is consistent with research findings up until the end of May suggesting that no specific therapy reduces ICU mortality. In the last few weeks dexamethasone has been found to have significant benefit and there is hope this will improve survival further.

Paper

‘Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies’ by R. A. Armstrong, A.D.Kane and T. M. Cook in Anaesthesia.

Notes to editors

For full embargoed paper, click here

Please note the above link is for journalists only. If you wish to provide a link to the paper for readers, please use the following, which will go live when the embargo lifts:

https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15201

 

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 2768
31-Jul-2020 4:05 PM EDT
The effects of COVID-19 on emergency visits, hospitalizations
Mayo Clinic

COVID-19 swept into the U.S., hospitals across the country have reported that their emergency departments are emptying out. In a new study published Monday, Aug. 3, in JAMA Internal Medicine, a team of researchers from multiple institutions provides insights into this phenomenon.

Newswise: Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
Released: 3-Aug-2020 10:20 AM EDT
Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
University of Kentucky

The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication. A monumental study in the field of dementia research is set to get underway in the coming weeks at UK.

Released: 3-Aug-2020 9:00 AM EDT
Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19
Neutrolis

Novel Chromatinase™ platform could rapidly and systemically removes NETs associated with exacerbation of COVID-19

Released: 3-Aug-2020 8:55 AM EDT
American College of Radiology to Provide Image Coordination for National COVID-19 Observational Study
American College of Radiology (ACR)

The American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) will serve as the imaging coordination center for the multicenter COVID-19 Observational Study (CORAL) led by Dr. Catherine "Terri" L. Hough of the Oregon Health & Science University. The CORAL Study is part of the Prevention & Early Treatment of Acute Lung Injury (PETAL) Network, a consortium of academic and affiliated hospitals across the United States – funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health – to conduct clinical trials in patients with or at risk for critical illness, including acute respiratory distress syndrome.

Released: 3-Aug-2020 8:35 AM EDT
Evaluating the effectiveness of travel bans
International Institute for Applied Systems Analysis

A new study sheds light on how COVID-19 spreads regionally and between countries, as well as on how effective governmental measures to curb the spread of the pandemic have been to date.

Newswise: Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Released: 3-Aug-2020 8:00 AM EDT
Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Iowa State University

Engineers are developing a no-touch, mail-in, fast-scan diagnostic sensing system that could be used to quickly test for COVID-19 or other outbreaks. The system would also produce a real-time outbreak map with demographic details.

Newswise: Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
30-Jul-2020 1:55 PM EDT
Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
American Association of Critical-Care Nurses (AACN)

Atrium Health’s tele-ICU quickly adjusted its patient-centered focus to include supporting and protecting bedside nurses caring for patients in isolation, as part of the system’s planning and preparations for the pandemic.

Released: 31-Jul-2020 5:05 PM EDT
Looking up to the Joneses: Consequences of the perceptions of white wealth
Society for Personality and Social Psychology

Before the era of COVID-19, research suggested that premature deaths among white Americans were rising. Even before the era of COVID-19, these findings were surprising.

Newswise: 238996_web.jpg
Released: 31-Jul-2020 4:55 PM EDT
Pooling strategy in the wake of the COVID-19 pandemic: A solution for mass population screening of SARS-CoV-2
Elsevier

In a report in the Journal of Molecular Diagnostics, published by Elsevier, researchers at Augusta University and PerkinElmer Genomics describe a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples.

Released: 31-Jul-2020 4:40 PM EDT
No racial disparities seen in response to remdesivir treatment of COVID-19
University of Chicago Medical Center

A new analysis by University of Chicago Medicine faculty, staff and collaborators around the world found remdesivir appears to be equally beneficial to patients regardless of race, supporting the need for early intervention and aggressive care for all patients in the fight against COVID-19.


Showing results

110 of 2768

close
0.93077